Last reviewed · How we verify
NCT03647930
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
NA trial testing Microporous Polysaccharide Hemospheres (MPH) in Seroma in 50 participants. Completed in 6 March 2015.
6 March 2015
Quick facts
| Lead sponsor | Memorial Health University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 15 May 2012 |
| Primary completion | 6 March 2015 |
| Estimated completion | 6 March 2015 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Microporous Polysaccharide Hemospheres (MPH)
Conditions studied
- Seroma — all drugs for Seroma →
Sponsor
Memorial Health University Medical Center
Who can join
18 and older, female only, with Seroma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial.
Suarez-Kelly LP, Pasley WH, Clayton EJ, Povoski SP, et al · · 2019 · cited 13× · PMID 30674296 · DOI 10.1186/s12885-019-5293-1
Verify or expand the search:
- PubMed search for NCT03647930
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Seroma
Currently open trials in the same condition.
- NCT07060781 — Management of Seroma After Posterior Lumbar Spine Decompression · recruiting
- NCT05899387 — Seroma of the Mammary Gland · NA · recruiting
- NCT05989386 — Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency L · Phase 2, PHASE3 · recruiting
- NCT04080934 — Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic · NA · recruiting
Other Memorial Health University Medical Center trials
Trials by the same sponsor.
- NCT03268395 — Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor · NA · unknown
- NCT03199560 — Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy · Phase 4 · unknown
- NCT03027115 — Hernia Surgery Urinary Retention · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03647930 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Health University Medical Center
- Last refreshed: 27 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03647930.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing